Surgery Doctors in Matthews, NC Accepting Medicare

7 Surgery doctors found. Showing 1 - 7

Ms. Iyore Amy-otabor James, M.D Surgery Medicare: Accepting Medicare Assignments Practice Location: 1450 Matthews Township Pkwy Ste 250, Matthews, NC 28105 Phone: 704-841-1444

Jeffrey Andrew Bohn, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 1450 Matthews Township Pkwy, Suite360, Matthews, NC 28105 Phone: 704-841-1444    Fax: 704-849-2520

Natalie Nowak, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1450 Matthews Township Pkwy Ste 250, Matthews, NC 28105 Phone: 704-841-1444    Fax: 704-849-2520

Christie Marianne Hirsch-reilly, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1450 Matthews Township Pkwy Ste 250, Matthews, NC 28105 Phone: 704-841-1444    Fax: 704-849-2520

Anna Blair Johnson, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1450 Matthews Township Pkwy Ste 230, Matthews, NC 28105 Phone: 704-384-8615    Fax: 704-384-6792

Cabrini L. Sutherland, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1450 Matthews Township Pkwy Ste 250, Matthews, NC 28105 Phone: 704-841-1444

Dr. Eric Lee Wallace, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1450 Matthews Township Pkwy Ste 250, Matthews, NC 28105 Phone: 704-841-1444    Fax: 704-849-2520

News Archive

New study reveals exosome-mediated communication between mother and baby

During pregnancy, the mother and the baby communicate in a variety of ways. For instance, signals from the fetus are crucially involved in the initiation of labor and delivery.

Dermatologist offers tips for sunscreen selection

Sunscreen can be a valuable tool for skin cancer prevention -; but only if it's used correctly. When applying sunscreen, many people make mistakes that could compromise their protection from the sun's harmful ultraviolet rays, which may increase their risk of skin cancer.

Santaris Pharma to discover and develop new RNA-based medicines for treating rare genetic disorders

Santaris Pharma A/S, a privately-held biopharmaceutical company focused on developing RNA-based drugs targeted to disease-related mRNAs and microRNAs, today announced a multi-year worldwide strategic alliance with Shire plc to discover and develop new RNA-based medicines to treat rare genetic disorders.

New technique harnesses 'natural barcodes' to facilitate better cell tracking

Each of us carries in our genomes about 10 million genetic variations called single nucleotide polymorphisms, which represent a difference of just one letter in the genetic code.

Read more Medical News

› Verified 9 days ago